Detalhe da pesquisa
1.
Peritoneal metastases from primary appendiceal and colorectal carcinomas demonstrate distinct molecular identities on comprehensive tumor analysis.
J Surg Oncol
; 127(5): 815-822, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36629137
2.
Impact of Sociodemographic Disparities and Insurance Status on Survival of Patients with Early-Onset Colorectal Cancer.
Oncologist
; 26(10): e1730-e1741, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34288237
3.
Early-onset pancreatic cancer: an institutional series evaluating end-of-life care.
Support Care Cancer
; 29(7): 3613-3622, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33170401
4.
Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma.
J Surg Oncol
; 121(8): 1320-1328, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32166754
5.
Advances in borderline resectable pancreatic adenocarcinoma.
Clin Adv Hematol Oncol
; 18(5): 280-288, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32628656
6.
Frequency of unplanned surgery in patients with stage IV colorectal cancer receiving palliative chemotherapy with an intact primary: An analysis of SEER-Medicare.
J Surg Oncol
; 120(3): 407-414, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31102466
7.
A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer.
Cancer
; 124(11): 2337-2346, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29579325
8.
Immuno-Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD-L1 Testing May Not Be Enough.
Oncologist
; 23(10): 1171-1177, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29703766
9.
Molecular Testing to Optimize and Personalize Decision Making in the Management of Colorectal Cancer.
Oncology (Williston Park)
; 31(4): 301-12, 2017 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28412781
10.
The challenge of measuring intra-individual change in fatigue during cancer treatment.
Qual Life Res
; 26(2): 259-271, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27469506
11.
Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer.
Eur J Cancer
; 201: 113914, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38359495
12.
Addressing barriers to increased adoption of DPYD genotyping at a large multisite cancer center.
Am J Health Syst Pharm
; 80(19): 1342-1349, 2023 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37235983
13.
COVID-19 vaccine uptake trends in SARS-CoV-2 previously infected cancer patients.
Vaccine X
; 14: 100289, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37020982
14.
A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies.
Cancer
; 118(21): 5403-13, 2012 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22570147
15.
Phase I trial of ixabepilone administered as three oral doses each separated by 6 hours every 3 weeks in patients with advanced solid tumors.
Invest New Drugs
; 30(6): 2364-70, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22331549
16.
Impact of a Clinical Genomics Program on Trial Accrual for Targeted Treatments: Practical Approach Overcoming Barriers to Accrual for Underserved Patients.
JCO Clin Cancer Inform
; 6: e2200011, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35839431
17.
Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers.
JCO Precis Oncol
; 6: e2100245, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35319967
18.
Association of Homologous Recombination-DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers.
Mol Cancer Ther
; 21(1): 227-236, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34725190
19.
Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma.
Clin Cancer Res
; 28(12): 2704-2714, 2022 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35302596
20.
Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer.
Oncogene
; 41(2): 260-267, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34728807